CME INDIA
  • Home
  • CME INDIA Repository
  • CME INDIA Case Study
  • CME INDIA Downloads
  • History Today in Medicine
  • Future CMEs
  • What is CME?
  • About CME INDIA
Select Page
SGLT2i and Urogenital Infections: India’s Largest Real-World Evidence Speaks

SGLT2i and Urogenital Infections: India’s Largest Real-World Evidence Speaks

by Admin | May 28, 2026 | CME INDIA Repository

CME INDIA Presentation by CME INDIA Team. This medical research article presents a large-scale, real-world study investigating the incidence of urogenital infections among over 15,000 type-2 diabetes patients across India. The findings reveal that patients using SGLT2...
SGLT2i and GTI/UTI-What Physicians Need to Know?

SGLT2i and GTI/UTI-What Physicians Need to Know?

by Admin | Jun 1, 2023 | CME INDIA Repository

CME INDIA Presentation by Dr. N.K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Based on a presentation at ADC-Bengaluru on 27th May 2023. Genitourinary infections are quite common among diabetic...
SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients – Part II

SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients – Part II

by Admin | Oct 15, 2022 | CME INDIA Repository

CME INDIA Presentation based on a case by Dr. Meena Chhabra, MD, Diabetologist, New Delhi and CME INDIA Discussion. Link to Part – I: SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients Part-2: Dr. A. K. Das, Diabetologist, Muzaffarpur: Doesn’t...
SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients

SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients

by Admin | Oct 13, 2022 | CME INDIA Repository

CME INDIA Presentation based on a case by Dr. Meena Chhabra, MD, Diabetologist, New Delhi and CME INDIA Discussion. Part-1: See this Urine Report: Dr. Meena Chhabra, Diabetologist, Delhi: 50 yr., Type 2 diabetic male with history of burning in micturition.Please see...
Is SGLT2-Inhibitors a New Nectar in Renal Protection in Diabetes?

Is SGLT2-Inhibitors a New Nectar in Renal Protection in Diabetes?

by Admin | Jun 9, 2022 | CME INDIA Repository

CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Based on the presentation at Diabetes India Conference 2022. Amazing changes in heart of SGLT2-Inhibitor treated...
« Older Entries

Latest Comments

  • Radha Raman Gupta on Dengue Prevention Enters a New Era in India
  • MULLAPUDI BHASKARA RAO, Advocate, Hyderabad on History Today in Medicine – Dr. Yellapragada Subbarao
  • Jaspal singh Ranyal. on History Today in Medicine – Prof. Dr. Balu Sankaran
  • VIDHYULATHA SANATA on Master Key to Success: Artificial Intelligence (AI) or Clinical Judgement
  • kiraneyecare on Living Legend in Medicine – Dr. A. Muruganathan

Latest Posts

  • History Today in Medicine – Dr. Gerhard Armauer Hansen
  • History Today in Medicine – Dr. Baruch S. Blumberg
  • History Today in Medicine – Dr. Emil Theodor Kocher
  • History Today in Medicine – Dr. Heinrich Adolf Rinne
  • History Today in Medicine – Dominique Jean Larrey

Explore CME INDIA

  • About CME INDIA
  • CME INDIA Case Study
  • CME INDIA Downloads
  • CME INDIA Home
  • CME INDIA Repository
  • Future CMEs
  • History Today in Medicine
  • What is CME?
© CME INDIA™ 2026. All content on this site is for academic discussion only. Propelled by Dynamic Cognition.